CODX vs TECH
Co-Diagnostics, Inc. Common Stock (CODX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CODX currently screens at market cap $31.4M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CODX and TECH stock pages for the full models.
Not investment advice.